Raymond James Maintains Outperform on First Foundation, Lowers Price Target to $25
Raymond James maintains First Foundation (NASDAQ:FFWM) with a Outperform and lowers the price target from $28 to $25.
Raymond James Maintains Outperform on Columbia Banking System, Lowers Price Target to $34
Raymond James maintains Columbia Banking System (NASDAQ:COLB) with a Outperform and lowers the price target from $38 to $34.
B. Riley Securities Maintains Buy on Peabody Energy, Lowers Price Target to $33
B. Riley Securities analyst Lucas Pipes maintains Peabody Energy (NYSE:BTU) with a Buy and lowers the price target from $34 to $33.
Raymond James Downgrades Sierra Bancorp to Market Perform
Raymond James analyst Donald Worthington downgrades Sierra Bancorp (NASDAQ:BSRR) from Outperform to Market Perform.
B. Riley Securities Maintains Buy on Alpha Metallurgical, Raises Price Target to $182
B. Riley Securities analyst Lucas Pipes maintains Alpha Metallurgical (NYSE:AMR) with a Buy and raises the price target from $181 to $182.
Why Merck Is Sending Seagen Stock Higher Today
Seagen Inc (NASDAQ: SGEN) shares are trading higher Thursday following reports suggesting Merck & Company Inc (NYSE: MRK) is in advanced talks to acquire the company.
Raymond James Maintains Outperform on Ameris, Lowers Price Target to $48
Raymond James maintains Ameris (NASDAQ:ABCB) with a Outperform and lowers the price target from $50 to $48.
BoJo Lost His Mojo: What Drove Boris Johnson’s Fall From Power As UK Prime Minister?
What a difference a day makes. Following yesterday’s bellicose pronouncement before the U.K.
Jefferies Downgrades CytomX Therapeutics to Hold, Lowers Price Target to $2
Jefferies analyst Roger Song downgrades CytomX Therapeutics (NASDAQ:CTMX) from Buy to Hold and lowers the price target from $12 to $2.
Raymond James Maintains Strong Buy on Triumph Bancorp, Lowers Price Target to $94
Raymond James analyst Michael Rose maintains Triumph Bancorp (NASDAQ:TBK) with a Strong Buy and lowers the price target from $125 to $94.